How artificial intelligence could unlock Parkinson’s greatest mysteries
Jonathan Rezek

​​​​​​​​​​​​​​​Can artificial intelligence help find a Parkinson’s treatment? IBM’s Jonathan Rezek is hopeful that it can.

​​It’s been 201 years since Parkinson’s disease was first described in detail. While researchers understand a lot more about it today, there’s still plenty that remains unknown

Jonathan Rezek first sensed that something was wrong when he froze onstage at a business conference in 2012. Normally, the affable IBM sales executive would have been in his element. He’d always thrived on the adrenalin rush of public speaking, and he could ad lib confidently without notes. But this time, instead of sharpening under pressure, he panicked.

"I was like a deer caught in the headlights. I wanted to run offstage," he says, sipping a herbal tea and recalling the experience at a Toronto café near IBM's downtown office, where he leads business development at an incubator for tech startups. For most people, a bout of stage fright wouldn't be too unusual; for Jonathan, the memory still resonates ominously – it was his first glimpse of a now-familiar foe.